anesthesia during laparoscopic surgery i.e. upper gastrointestinal, lower gastrointestinal, urological and gynecological anesthesia narcosis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Patients scheduled for elective laparoscopic procedure with a complexity according to the BUPA classification for case complexity: *MAJOR*, *MAJOR PLUS* or *COMPLEX MAJOR* • ASA class I-III • >= 18 years of age • Ability to give oral and written informed consent
Exclusion criteria
Exclusion criteria: • Low or intermediate complexity laparoscopic procedures (BUPA *SIMPLE* or *INTER*) • Known or suspected neuromuscular disorders impairing neuromuscular function • Allergies to muscle relaxants, anesthetics or narcotics mentioned • A (family) history of malignant hyperthermia • Women who are or may be pregnant or are currently breast feeding • Chronic use of any type of opioid or psychotropic drug • Use of NSAID*s shorter than 5 days before surgery for the treatment of chronic pain • Indication for rapid sequence induction • Contra-indication for sugammadex use (e.g. known sugammadex allergy or GFR
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Objectives: To study the effect of deep neuromuscular block compared to standard neuromuscular block on intra-operative adverse events during laparoscopic surgery using the CLASSIC score system; | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the effect of deep neuromuscular block as compared to standard neuromuscular block on: • Surgical working conditions (L-SRS) • 30 day post-operative complications (Clavien-Dindo,) • 30-day post-operative complications according to the Comprehensive Complication Index (https://www.assessurgery.com/) • 30 day unplanned readmission rates • Quality of recovery at post-operative day 1 and 2 after laparoscopic surgery.(QoR 40) • Quality-of-life at postoperative day 30 (SF36) | — |
Countries
Netherlands